#USA #Nashville #DAXXIFY #Revance #Ingredient Awareness

Consumer Awareness on Ingredients: A Closer Look

A new survey sheds light on a significant disparity in consumer awareness regarding beauty and wellness products. While a staggering 91% of Americans claim to be more ingredient-conscious than in the past, this awareness often does not extend to aesthetic treatments, particularly injectable frown line treatments. Despite being a popular choice among consumers, many are unaware of the essential differences in formulations available on the market.

Key Survey Findings

Commissioned by Revance and conducted by Talker Research, the survey engaged 2,000 U.S. adults aged 30 to 54 who are current or prospective users of neurotoxin treatments for frown lines, such as Botox and its alternatives. The findings reveal a intertwined relationship between ingredient awareness and consumer habits:

• - Increasing Ingredient Awareness: 91% of respondents reported heightened ingredient awareness, especially in skincare and wellness products. The primary motivators for researching product ingredients include ensuring efficacy (61%), managing allergies (41%), and distinguishing between products (36%).
• - Role of Technology: Interestingly, 31% of participants noted that artificial intelligence tools have started assisting them in making informed ingredient decisions.
• - Blind Spots in Frown Line Treatments: Despite this general awareness, fewer than half of the respondents could name a single ingredient in an available neurotoxin treatment. Alarmingly, 53% incorrectly believe that all formulations for frown line treatments are essentially the same, disregarding crucial differences that affect their health and beauty choices.

Understanding Product Differences

The survey laid bare a significant knowledge gap regarding common treatment ingredient formulations. Many respondents seemed uninformed about the presence of human or animal-based components in many neurotoxin treatments. This is where Revance aims to make a difference with their product, DAXXIFY®, which is distinguished by its innovative peptide formulation that does not rely on animal or human-based ingredients—all while effectively stabilizing the active compound.

Among those surveyed, it stands out that 36% chose their current treatment option because it was the most apparent choice at the time, and another 32% admitted they were not even aware of alternative options. However, a silver lining appears as 61% mentioned that they would consider switching to another treatment based on the ingredients and formulations used.

Revance’s Educational Initiative

To bridge this educational gap, Revance is launching an informational campaign designed to empower consumers with knowledge about aesthetic treatments and their compositions. As Jeff Bedard, the CEO of Revance, noted, "Too often, frown line treatments are treated as interchangeable, disregarding their distinct formulations that could significantly affect outcomes and experiences. Too few people understand the unique benefits of peptide formulations like that in DAXXIFY®."

This campaign not only aims to promote ingredient knowledge but also engages consumers by offering them an opportunity to win a DAXXIFY® Dream Getaway, which includes a treatment experience. Revance hopes to enlighten consumers about their choices in aesthetic treatments, thus enhancing the overall market for safer, more informed beauty decisions.

Conclusion

In summary, while consumers are increasingly aware and diligent about the products they apply or ingest, there remains a noticeable blind spot regarding injectable frown line treatments. With initiatives like Revance’s educational campaign and the introduction of unique products like DAXXIFY®, there’s a pathway toward greater consumer understanding, helping them make more informed choices in their journey toward beauty and wellness. Consumers are encouraged to consult their healthcare providers about ingredient options and to explore resources provided by Revance for further learning.